Instalab

Latex (Hev b 6.02) IgE Test Blood

The most accurate signal that your latex sensitivity is the real, reaction-causing kind, not a harmless lab finding.

Should you take a Latex (Hev b 6.02) IgE test?

This test is most useful if any of these apply to you.

Working Around Latex Gloves
Daily glove or scrub wearing can push exposure into true allergy. This test reveals if you're at risk for asthma or anaphylaxis.
Reacting to Avocado, Banana, or Kiwi
Latex and these fruits share one specific protein. A positive result explains the connection your food panel can miss.
Had a Reaction During Surgery
If an unexplained reaction occurred during surgery or a dental visit, this test confirms or rules out latex before your next procedure.
Positive Standard Latex Test, No Symptoms
Routine testing flagged latex but you have no symptoms. This sorts true allergy from harmless cross-reactivity, so you know if avoidance matters.

About Latex (Hev b 6.02) IgE

If you work around latex gloves, have had a strange reaction during surgery, or react to avocado, banana, or kiwi, this is the test that can tell you whether your immune system is genuinely primed for a serious latex reaction. A standard latex blood test often comes back positive in people who never have symptoms, and negative in people who clearly do. This component test cuts through that noise.

It looks for IgE antibodies aimed at hevein, the single most important latex protein in real-world allergic reactions. A positive result here is far more meaningful than a generic latex antibody result, and a negative result in someone with a positive standard test is reassuring rather than alarming.

What This Test Actually Measures

This test measures Hev b 6.02 IgE (immunoglobulin E antibodies against hevein) in your blood. Hevein is one of more than a dozen proteins found in natural rubber latex from the Hevea brasiliensis tree, and across multiple studies it stands out as the main protein driving true allergic reactions in adults exposed to latex gloves. When your immune system has manufactured antibodies against hevein, those antibodies sit on the surface of immune cells called mast cells and basophils, ready to trigger an allergic reaction the next time you encounter latex.

This is different from a standard latex IgE test, which uses a crude mixture of latex proteins. The crude test picks up antibodies against any latex protein, including ones that rarely cause symptoms. The hevein-specific test isolates the one protein most likely to matter.

Why Hevein Stands Out Among Latex Proteins

In a study of healthcare workers sensitized to latex gloves, hevein-specific IgE emerged as the most important single allergen. In a study of latex-induced occupational asthma, high antibody levels against hevein combined with another latex protein (Hev b 5) were the strongest predictors that a worker would actually react when challenged with latex in a controlled inhalation test.

In children with latex-fruit syndrome, the cross-reactive allergic pattern where latex sensitivity overlaps with reactions to avocado, banana, kiwi, and chestnut, hevein has been identified as the major cross-reacting protein between latex and avocado. If you react to certain tropical fruits and suspect latex is involved, this test is one of the clearest ways to confirm it.

Occupational Asthma and Workplace Reactions

Latex allergy in healthcare and laboratory workers is the most studied scenario for this biomarker. Powdered latex gloves release allergenic proteins into the air, and inhalation can trigger rhinitis, asthma, and in some cases anaphylaxis. The challenge for clinicians has been separating workers with true latex-induced asthma from those whose asthma is merely worse at work for unrelated reasons.

In a study of 107 workers with suspected latex-induced occupational asthma, high antibody levels against hevein combined with the related Hev b 5 protein had a positive predictive value above 95% for a positive bronchial response during a controlled latex challenge, with 79% sensitivity. By comparison, the standard crude latex IgE test at a positivity threshold of 0.35 kUA/L had 94% sensitivity but only 48% specificity, meaning roughly half of positive results were misleading.

Surgical and Procedural Risk

Intra-operative anaphylaxis caused by latex gloves, catheters, or drains is one of the most serious manifestations of this allergy. Component-resolved studies suggest that patients sensitized to hevein and the related Hev b 6 protein family are the ones most likely to have severe reactions during procedures. A negative hevein result in someone with a positive standard latex test points toward harmless sensitization (often driven by a cross-reactive plant protein called profilin) rather than true risk.

Children with spina bifida and those who have undergone multiple surgeries are traditionally considered the highest-risk group. In these patients, antibody patterns are more complex, involving Hev b 1, Hev b 3, and Hev b 5 in addition to hevein. A negative hevein test alone does not rule out risk in this group, but a positive one strengthens the case for strict latex avoidance during medical care.

Latex-Fruit Syndrome

About a third to half of people with latex allergy also react to certain plant foods, particularly avocado, banana, kiwi, chestnut, and papaya. The protein in latex that cross-reacts with avocado has been identified as hevein itself. If you have unexplained reactions to these fruits, especially alongside any glove or balloon sensitivity, a positive result here clarifies the underlying mechanism and explains the link your standard food and latex panels may have missed.

Why One Reading Is Not Enough

Allergen-specific IgE levels can drift over time, particularly with changing exposure. A worker who leaves a high-latex environment may see antibody levels fall over months to years; ongoing daily exposure tends to keep them stable or push them higher. This is exactly why a single number tells you less than a trend does.

For someone using this test to monitor occupational risk or to track response to strict avoidance, the practical approach is a baseline test now, a repeat in 6 to 12 months if your exposure has changed, and at least annual monitoring if you continue working around latex. If you are starting allergen immunotherapy for latex, your clinician will likely want to follow specific IgE alongside other functional markers, since a drop in symptoms does not always show up as a drop in IgE.

What to Do With an Unexpected Result

A positive hevein result, especially with even a vague history of glove rashes, itchy hands at work, or reactions during procedures, should push you to act, not wait. The next step is an evaluation with an allergist who can confirm the picture with skin prick testing and a detailed history, and who can give you written guidance for latex-safe medical care. Tell every dental office, surgical center, and emergency contact about your diagnosis, and consider wearing a medical alert.

A negative hevein result in someone with a positive standard latex IgE test is genuinely reassuring. It usually points to sensitization through a cross-reactive plant protein (most often Hev b 8, called profilin) that almost never causes clinical latex reactions. In that case, the next step is to investigate pollen and plant-food sensitivities rather than treat latex itself as a danger.

If results are equivocal or your symptoms remain unexplained, companion testing with Hev b 5, Hev b 1, and Hev b 3 builds a fuller component-resolved profile. Together they distinguish occupational allergy patterns from spina bifida patterns and from cross-reactive sensitizations.

When Results Can Be Misleading

A single allergen-specific IgE measurement can sometimes mislead. Watch for the following:

  • Recent allergen exposure: a major latex contact in the days before the draw can transiently shift antibody levels, though long-term trends matter more than a single value.
  • Very high total IgE: people with severe atopic dermatitis or parasitic infections can have generally elevated IgE that increases the chance of weak, clinically unimportant positives.
  • Assay differences: different laboratories use different platforms (such as ImmunoCAP versus ISAC microarray), and reported sensitivities for latex sensitization range from 55% on one platform to 70% on another, so switching labs mid-monitoring can introduce artificial changes.
  • Profilin and cross-reactive carbohydrate sensitization: if your immune system is reacting to the cross-reactive Hev b 8 protein or to plant sugar markers, a crude latex test can be positive while this hevein-specific test is correctly negative. That mismatch is informative, not an error.

What Moves This Biomarker

Evidence-backed interventions that affect your Latex (Hev b 6.02) IgE level

Decrease
Strict avoidance of latex exposure in occupational settings
Removing ongoing exposure to powdered latex gloves and other latex-containing medical and industrial products lowers immune stimulation over months to years. In healthcare worker cohorts, those continuing to work with high-protein powdered latex gloves show the highest sensitization rates to hevein, while transition to non-latex or low-protein alternatives is associated with lower sensitization prevalence. Avoidance is the foundation of management because it both reduces reaction risk and gradually quiets the immune response.
LifestyleModerate Evidence
Decrease
Sublingual latex immunotherapy (drops under the tongue containing latex allergen)
Sublingual immunotherapy targets the underlying latex allergy itself, not just symptoms. In a study of 23 children with latex allergy, hevein-specific IgE in blood did not change dramatically, but basophil reactivity to hevein decreased and clinical tolerance to latex improved. So while the lab number may not move much, the immune response that drives your reactions can.
MedicationModest Evidence

Frequently Asked Questions

References

15 studies
  1. Vandenplas O, Froidure a, Meurer U, Rihs H, Rifflart C, Soetaert S, Jamart J, Pilette C, Raulf MAllergy2016
  2. Nowakowska-świrta E, Wiszniewska M, Walusiak-skorupa JJournal of Occupational Health2019
  3. Ebo D, Hagendorens M, De Knop K, Verweij M, Bridts C, De Clerck L, Stevens WClinical & Experimental Allergy2010
  4. Sanz M, García-avilés M, Tabar a, Anda M, García BE, Barber D, Salcedo G, Rihs H, Raulf-heimsoth MPediatric Allergy and Immunology2006